Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. (CPIX) Stock Overview

Explore Cumberland Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

CPIX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$7.96
$1.26(18.81%)
U.S. Market opens in 6h 12m

Cumberland Pharmaceuticals Inc. (CPIX)

Meyka AI Score

Z

Key Financials

Market Cap119.3M
P/E Ratio-10.85
EPS (TTM)$-0.40
ROE-0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$4.85
3 Months$9.89
1 Year Target$6.94

CPIX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cumberland Pharmaceuticals Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CPIX on the NASDAQ shows an RSI of 58.91, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.94 for the NASDAQ listing.

Key metrics behind Cumberland Pharmaceuticals Inc.'s NASDAQ-traded stock include a P/E ratio of -10.85 and a market capitalization of 119.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CPIX on the NASDAQ.

Price Performance (NASDAQ: CPIX)

1-Day Change
18.81%
5-Day Change
6.28%
1-Month Change
8.74%
3-Month Change
9.04%
6-Month Change
152.70%
Year-to-Date (YTD) Change
100.00%
1-Year Change
123.60%
3-Year Change
273.71%
5-Year Change
200.38%
All-Time (Max) Change
-52.70%

Contact Information

https://www.cumberlandpharma.com
615 255 0068
2525 West End Avenue, Nashville, TN, 37203

Company Facts

880 Employees
IPO DateAug 11, 2009
CountryUS
Actively Trading

Frequently Asked Questions